688639 华恒生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产1,178,9497.99%1,091,692762,921463,105390,440
在建工程1,789,38517.07%1,528,530188,91165,33021,171
无形资产84,731-1.79%86,27673,17443,98041,531
商誉0--0000
其他非流动资产258,39020.92%213,694139,02549,19128,162
3,311,45513.40%2,920,1921,164,030621,606481,304

流动资产
货币资金393,54311.49%352,984147,464121,78862,200
应收账款270,66110.14%245,748260,386175,79688,488
存货263,63816.41%226,464135,514106,20847,106
其他流动资产253,22112.62%224,850319,692448,70863,788
1,181,06312.48%1,050,046863,055852,501261,582

流动负债
短期借款1,165,98427.41%915,12179,22818,49955,065
应付票据0--0000
应付帐款576,513-2.12%589,006221,64399,86886,845
其他流动负债277,63161.08%172,35187,88464,52819,729
2,020,12820.50%1,676,479388,754182,895161,639
流动资产净值(839,065)33.94%(626,432)474,301669,60699,943
资产总额减流动负债2,472,3907.79%2,293,7591,638,3311,291,212581,247

非流动负债
长期借款458,00250.20%304,933000
应付债券0--0000
其他非流动负债180,90710.87%163,165156,686108,08791,467
638,90936.49%468,099156,686108,08791,467

总权益
    实收股本157,8100.17%157,540108,400108,40081,000
    储备项目1,678,6970.56%1,669,4311,372,0941,074,725408,780
股东权益1,836,5070.52%1,826,9711,480,4941,183,125489,780
非控股权益(3,026)130.99%(1,310)1,15100